Page last updated: 2024-11-10

demethoxysudachitin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

demethoxysudachitin: from Lysionotus denticutosus & pauciflorus var. Catifolius [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Lysionotusgenus[no description available]Gesneriaceae[no description available]

Cross-References

ID SourceID
PubMed CID3083845
CHEMBL ID476120
CHEBI ID174446
SCHEMBL ID2180082
MeSH IDM0210078

Synonyms (19)

Synonym
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethoxy-
4',5,7-trihydroxy-6,8-dimethoxyflavone
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethoxychromen-4-one
CHEBI:174446
4323-80-2
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethoxy-chromen-4-one
5,7-dihydroxy-2-(4-hydroxy-phenyl)-6,8-dimethoxy-chromen-4-one
demethoxysudachitin
CHEMBL476120 ,
3'-demethoxysudachitin
desmethoxysudachitin
LMPK12111444
5,7,4'-trihydroxy-6,8-dimethoxyflavone
bdbm50412280
SCHEMBL2180082
DTXSID20195801
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethoxy-4h-1-benzopyran-4-one
desmethoxysudachin
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethoxy-4h-chromen-4-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
flavonoidsAny organic molecular entity whose stucture is based on derivatives of a phenyl-substituted 1-phenylpropane possessing a C15 or C16 skeleton, or such a structure which is condensed with a C6-C3 lignan precursors. The term is a 'superclass' comprising all members of the classes of flavonoid, isoflavonoid, neoflavonoid, chalcones, dihydrochalcones, aurones, pterocarpan, coumestans, rotenoid, flavonolignan, homoflavonoid and flavonoid oligomers. Originally restricted to natural products, the term is also applied to synthetic compounds related to them.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)0.40740.00041.877310.0000AID342547
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID378075Antimicrobial activity against Helicobacter pylori ATCC 43504 at 100 ug/disk after 4 days by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
AID342547Inhibition of rat lens aldose reductase2008Bioorganic & medicinal chemistry, Aug-01, Volume: 16, Issue:15
QSAR prediction of inhibition of aldose reductase for flavonoids.
AID378071Antimicrobial activity against methicillin-resistant Staphylococcus aureus COL at 100 ug/disk after 24 hrs by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
AID378073Antimicrobial activity against methicillin-resistant Staphylococcus aureus 5 at 100 ug/disk after 24 hrs by disk diffusion method2006Journal of natural products, Aug, Volume: 69, Issue:8
Chemical constituents from the peels of Citrus sudachi.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.97 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]